We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+9.51%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$28.5B
AUM Growth
+$2.42B
(+9.3%)
Cap. Flow
+$581M
Cap. Flow
% of AUM
2.04%
Top 10 Holdings %
Top 10 Hldgs %
19.66%
Holding
1,921
New
171
Increased
1,320
Reduced
356
Closed
71
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$111M |
| 2 |
VF Corp
VFC
|
+$73.4M |
| 3 |
Amazon
AMZN
|
+$71M |
| 4 |
Stanley Black & Decker
SWK
|
+$60.2M |
| 5 |
Tesla
TSLA
|
+$46.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Target
TGT
|
+$158M |
| 2 |
Apple
AAPL
|
+$130M |
| 3 |
Cardinal Health
CAH
|
+$43.7M |
| 4 |
Fortinet
FTNT
|
+$39.6M |
| 5 |
ExxonMobil
XOM
|
+$32.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.73% |
| 2 | Industrials | 12.07% |
| 3 | Consumer Staples | 11.64% |
| 4 | Healthcare | 11.12% |
| 5 | Financials | 10.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
Healthcare Realty
HR
$7.42B
| $1.39M | ﹤0.01% |
71,922
+4,916
| +7% | +$96.6K |
|
677
Emcor
EME
$33.1B
| $1.36M | ﹤0.01% |
9,183
+957
| +12% | +$136K |
|
678
Markel Group
MKL
$25B
| $1.35M | ﹤0.01% |
1,028
+120
| +13% | +$148K |
|
679
Fair Isaac
FICO
$28.7B
| $1.35M | ﹤0.01% |
2,247
+84
| +4% | +$44.2K |
|
680
Wolfspeed
WOLF
$1.2B
| $1.34M | ﹤0.01% |
19,448
+885
| +5% | +$78.5K |
|
681
Commercial Metals
CMC
$7.63B
| $1.33M | ﹤0.01% |
27,471
+2,094
| +8% | +$96K |
|
|
KRTX
682
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $1.32M | ﹤0.01% |
6,732
+582
| +9% | +$125K |
|
683
F5
FFIV
$22.1B
| $1.32M | ﹤0.01% |
9,180
-186
| -2% | -$27.2K |
|
684
LPL Financial
LPLA
$26.3B
| $1.31M | ﹤0.01% |
6,083
-10,819
| -64% | -$2.53M |
|
685
Reinsurance Group of America
RGA
$15.7B
| $1.31M | ﹤0.01% |
9,223
+1,060
| +13% | +$148K |
|
686
Rollins
ROL
$18.6B
| $1.31M | ﹤0.01% |
35,777
-15,786
| -31% | -$613K |
|
687
Brixmor Property Group
BRX
$9.95B
| $1.28M | ﹤0.01% |
56,676
+3,909
| +7% | +$83.7K |
|
688
Silicon Laboratories
SLAB
$7.15B
| $1.28M | ﹤0.01% |
9,462
+554
| +6% | +$72.8K |
|
689
Valley National Bancorp
VLY
$7.93B
| $1.28M | ﹤0.01% |
113,443
+14,757
| +15% | +$174K |
|
690
East-West Bancorp
EWBC
$17.9B
| $1.28M | ﹤0.01% |
19,451
+2,288
| +13% | +$157K |
|
691
Crocs
CROX
$6.69B
| $1.27M | ﹤0.01% |
11,746
+1,589
| +16% | +$141K |
|
|
MPT
692
Medical Properties Trust
MPT
$2.89B
| $1.26M | ﹤0.01% |
113,008
+7,537
| +7% | +$87.6K |
|
693
Reliance Steel & Aluminium
RS
$20.8B
| $1.26M | ﹤0.01% |
6,215
+199
| +3% | +$39.6K |
|
694
Iridium Communications
IRDM
$4.85B
| $1.26M | ﹤0.01% |
24,454
+2,788
| +13% | +$140K |
|
695
Vontier
VNT
$4.33B
| $1.24M | ﹤0.01% |
64,186
+858
| +1% | +$16.1K |
|
696
Omega Healthcare
OHI
$15.4B
| $1.24M | ﹤0.01% |
44,255
+3,027
| +7% | +$91.3K |
|
697
Bio-Rad Laboratories Class A
BIO
$8.42B
| $1.22M | ﹤0.01% |
2,909
+31
| +1% | +$12.5K |
|
698
Arrowhead Research
ARWR
$12.1B
| $1.22M | ﹤0.01% |
30,145
+2,424
| +9% | +$80.3K |
|
699
Universal Health Services
UHS
$9.43B
| $1.22M | ﹤0.01% |
8,670
-242
| -3% | -$28.6K |
|
700
EastGroup Properties
EGP
$11.5B
| $1.22M | ﹤0.01% |
8,234
+562
| +7% | +$84.8K |
|
Similar funds
ProShare Advisors's Q4 2022 Portfolio in Review
As of Q4 2022, ProShare Advisors held 1,921 positions worth $28.5B, up 9.3% from $26.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
ProShare Advisors's Q4 2022 filing shows 171 new, 1,320 increased, 356 reduced and 71 closed positions. Its largest new stake was Rivian: 689,839 shares worth $12.7M. The largest sale was Target, an estimated $158M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Industrials and Consumer Staples.
- ProShare Advisors's largest Q4 2022 buy was Rivian: 689,839 shares worth $12.7M.
- ProShare Advisors added most to Microsoft in Q4 2022, an estimated $111M increase.
- ProShare Advisors's biggest Q4 2022 reduction was Apple, cutting an estimated $130M.
- ProShare Advisors fully exited Target in Q4 2022, selling an estimated $158M.
- ProShare Advisors's ten largest holdings make up 20% of its $28.5B portfolio in Q4 2022.
- ProShare Advisors opened 171 new positions and closed 71 in Q4 2022.
- ProShare Advisors's portfolio value rose 9.3% quarter-over-quarter to $28.5B.
Based on ProShare Advisors's 13F filing for Q4 2022, filed 2 Feb 2023.